Patients with vs without systemic sclerosis have an increased risk for future cancer diagnoses, according to study findings.

Researchers found a 13% improvement in survival outcomes among patients with melanoma using statins vs patients with melanoma not using statins.

A 1-dose human papillomavirus vaccination program is projected to prevent a similar number of cervical cancers as a 2-dose program.

Among patients with first primary cutaneous melanoma, White patients had the highest absolute risk of second primary melanomas.

For patients with hidradenitis suppurativa, bimekizumab is safe and efficacious over 2 years, according to study findings.